Clinical Research Division, Fred Hutch
Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia, or CLL, as well as immunotherapy (specifically CAR T cell therapy) for lymphoid neoplasms and blood stem cell transplant for hematologic malignancies. His goal is to identify the best treatment sequence or combination for patients with high-risk lymphoma and CLL.
Attending Physician, Hematologic Malignancies
Seattle Cancer Care Alliance
Associate Professor, Medical Oncology Division
University of Washington School of Medicine
Hematology and Medical Oncology fellowship, University of Washington/Fred Hutchinson Cancer Research Center, 2011-2014
Internal Medicine Residency, Cleveland Clinic, 2008-2011
M.P.H., Cancer Epidemiology, University of Washington, 2008
M.D., Tehran University of Medical Sciences, 2004
Therapeutic clinical trials in lymphoid malignancies with a focus on chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
Clinical outcome research in hematopoietic cell transplantation
Epidemiology of hematologic malignancies
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email firstname.lastname@example.org or call 206.667.2210